|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neuroradiology |
1 From the Departments of Radiology (M.L., S.C., E.A.K., G.J., J.A., A.W.L.) and Neurosurgery (E.A.K.), NYU Medical Center, 560 First Ave, RIM Rm 234, New York, NY 10016. From the 2000 RSNA scientific assembly. M.L. supported by a 2000 RSNA Fellow Research Trainee Prize and a grant from the Royal Australian and New Zealand College of Radiologists. S.C. supported by an RSNA Seed Grant. Received March 5, 2001; revision requested April 12; revision received July 9; accepted August 15. Address correspondence to M.L. (e-mail: lawm01@med.nyu.edu).
PURPOSE: To determine whether perfusion-weighted and proton spectroscopic MR imaging can be used to differentiate high-grade primary gliomas and solitary metastases on the basis of differences in vascularity and metabolite levels in the peritumoral region.
MATERIALS AND METHODS: Fifty-one patients with a solitary brain tumor (33 gliomas, 18 metastases) underwent conventional, contrast materialenhanced perfusion-weighted, and proton spectroscopic MR imaging before surgical resection or stereotactic biopsy. Of the 33 patients with gliomas, 22 underwent perfusion-weighted MR imaging; nine, spectroscopic MR imaging; and two underwent both. Of the 18 patients with metastases, 12 underwent perfusion-weighted MR imaging, and six, spectroscopic MR imaging. The peritumoral region was defined as the area in the white matter immediately adjacent to the enhancing (hyperintense on T2-weighted images, but not enhancing on postcontrast T1-weighted images) portion of the tumor. Relative cerebral blood volumes in these regions were calculated from perfusion-weighted MR data. Spectra from the enhancing tumor, the peritumoral region, and normal brain were obtained from the two-dimensional spectroscopic MR acquisition. The Student t test was used to determine if there was a statistically significant difference in relative cerebral blood volume and metabolic ratios between high-grade gliomas and metastases.
RESULTS: The measured relative cerebral blood volumes in the peritumoral region in high-grade gliomas and metastases were 1.31 ± 0.97 (mean ± SD) and 0.39 ± 0.19, respectively. The difference was statistically significant (P < .001). Spectroscopic imaging demonstrated elevated choline levels (choline-to-creatine ratio was 2.28 ± 1.24) in the peritumoral region of gliomas but not in metastases (choline-to-creatine ratio was 0.76 ± 0.23). The difference was statistically significant (P = .001).
CONCLUSION: Although conventional MR imaging characteristics of solitary metastases and primary high-grade gliomas may sometimes be similar, perfusion-weighted and spectroscopic MR imaging enable distinction between the two.
© RSNA, 2002
Index terms: Brain neoplasms, diagnosis, 13.363, 13.3634, 13.38 Brain neoplasms, MR, 13.121412, 13.121415, 13.121416, 13.12143, 13.12144, 13.12145 Brain neoplasms, secondary, 13.38 Magnetic resonance (MR), spectroscopy, 13.12144, 13.12145 Magnetic resonance (MR), perfusion study, 13.12144, 13.12145
This article has been cited by other articles:
![]() |
P.H. Lai, H.H. Weng, C.Y. Chen, S.S. Hsu, S. Ding, C.W. Ko, J.H. Fu, H.L. Liang, and K.H. Chen In Vivo Differentiation of Aerobic Brain Abscesses and Necrotic Glioblastomas Multiforme Using Proton MR Spectroscopic Imaging AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1511 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chawla, S. Wang, R.L. Wolf, J.H. Woo, J. Wang, D.M. O'Rourke, K.D. Judy, M.S. Grady, E.R. Melhem, and H. Poptani Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1683 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Lupo, S. Cha, S.M. Chang, and S.J. Nelson Analysis of Metabolic Indices in Regions of Abnormal Perfusion in Patients with High-Grade Glioma AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1455 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ricci, A. Bacci, V. Tugnoli, S. Battaglia, M. Maffei, R. Agati, and M. Leonardi Metabolic Findings on 3T 1H-MR Spectroscopy in Peritumoral Brain Edema AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1287 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kwee, J. P. Ko, C. S. Jiang, M. R. Watters, and M. N. Coel Solitary Brain Lesions Enhancing at MR Imaging: Evaluation with Fluorine 18 Fluorocholine PET Radiology, August 1, 2007; 244(2): 557 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cha, J.M. Lupo, M.-H. Chen, K.R. Lamborn, M.W. McDermott, M.S. Berger, S.J. Nelson, and W.P. Dillon Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1078 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Fine, J. Chen, C. Balmaceda, J. N. Bruce, M. Huang, M. Desai, M. B. Sisti, G. M. McKhann, R. R. Goodman, J. S. Bertino Jr., et al. Randomized study of Paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors. Clin. Cancer Res., October 1, 2006; 12(19): 5770 - 5776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Al-Okaili, J. Krejza, S. Wang, J. H. Woo, and E. R. Melhem Advanced MR Imaging Techniques in the Diagnosis of Intraaxial Brain Tumors in Adults RadioGraphics, October 1, 2006; 26(suppl_1): S173 - S189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Sorensen Magnetic Resonance As a Cancer Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3274 - 3281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology, June 27, 2006; 66(12): 1899 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Chen, C.-W. Li, Y.-T. Kuo, T.-S. Jaw, D.-K. Wu, J.-C. Jao, J.-S. Hsu, and G.-C. Liu Early Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization: Choline Levels and MR Diffusion Constants--Initial Experience Radiology, May 1, 2006; 239(2): 448 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cha Update on Brain Tumor Imaging: From Anatomy to Physiology AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 475 - 487. [Full Text] [PDF] |
||||
![]() |
Y.M. Tang, S. Ngai, and S. Stuckey The Solitary Enhancing Cerebral Lesion: Can FLAIR Aid the Differentiation between Glioma and Metastasis? AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 609 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stadlbauer, S. Gruber, C. Nimsky, R. Fahlbusch, T. Hammen, R. Buslei, B. Tomandl, E. Moser, and O. Ganslandt Preoperative Grading of Gliomas by Using Metabolite Quantification with High-Spatial-Resolution Proton MR Spectroscopic Imaging Radiology, March 1, 2006; 238(3): 958 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Patankar, H. A. Haroon, S. J. Mills, D. Baleriaux, D. L. Buckley, G. J.M. Parker, and A. Jackson Is Volume Transfer Coefficient (Ktrans) Related to Histologic Grade in Human Gliomas? AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2455 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulakbasi, M. Kocaoglu, A. Farzaliyev, C. Tayfun, T. Ucoz, and I. Somuncu Assessment of Diagnostic Accuracy of Perfusion MR Imaging in Primary and Metastatic Solitary Malignant Brain Tumors AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2187 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Brubaker, E. Bullitt, C. Yin, T. Van Dyke, and W. Lin Magnetic Resonance Angiography Visualization of Abnormal Tumor Vasculature in Genetically Engineered Mice Cancer Res., September 15, 2005; 65(18): 8218 - 8223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lupo, S. Cha, S. M. Chang, and S. J. Nelson Dynamic Susceptibility-Weighted Perfusion Imaging of High-Grade Gliomas: Characterization of Spatial Heterogeneity AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1446 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, M. Law, G. Johnson, J. Herbert, J. S. Babb, L. J. Mannon, and R. I. Grossman Dynamic Susceptibility Contrast Perfusion MR Imaging of Multiple Sclerosis Lesions: Characterizing Hemodynamic Impairment and Inflammatory Activity AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1539 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Aberle, C. Chiles, C. Gatsonis, B. J. Hillman, C. D. Johnson, B. L. McClennan, D. G. Mitchell, E. D. Pisano, M. D. Schnall, and A. G. Sorensen Imaging and Cancer: Research Strategy of the American College of Radiology Imaging Network Radiology, June 1, 2005; 235(3): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nimsky, O. Ganslandt, B. von Keller, J. Romstock, and R. Fahlbusch Intraoperative High-Field-Strength MR Imaging: Implementation and Experience in 200 Patients Radiology, October 1, 2004; 233(1): 67 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Herrmann, B. Sporer, and T. A. Yousry Thrombosis of the Internal Cerebral Vein Associated with Transient Unilateral Thalamic Edema: A Case Report and Review of the Literature AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1351 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Brown, J. T. Wald, M. W. McDermott, G. S. Baumann, and T. F. Cloughesy Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma. RadioGraphics, November 1, 2003; 23(6): 1591 - 1611. [Full Text] [PDF] |
||||
![]() |
E. Saraf-Lavi, B. C. Bowen, P. M. Pattany, E. M.L. Sklar, J. B. Murdoch, and C. K. Petito Proton MR Spectroscopy of Gliomatosis Cerebri: Case Report of Elevated Myoinositol with Normal Choline Levels AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 946 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Saindane, S. Cha, M. Law, X. Xue, E. A. Knopp, and D. Zagzag Proton MR Spectroscopy of Tumefactive Demyelinating Lesions AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1378 - 1386. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |